A randomized controlled trial of a protocol of interviews designed to improve adherence to antiretroviral medications in Southern Brazil

International Journal of STD and AIDS

Volumn 23, Issue 6, 2012, Pages 429-434

  Zubaran, C ^a,b,c   Michelim, L ^c   Medeiros, G ^c   May, W ^c   Foresti, K ^b,c   Madi, J M ^c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b Western sydney Local Health District ^*  (Australia)

^c UNIVERSITY OF CAXIAS DO SUL   (Brazil)

Author keywords

Antiretroviral therapy; Brazil; HIV; Medication adherence; Patient compliance

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR;

ADULT; ARTICLE; BRAZIL; CLINICAL ASSESSMENT TOOL; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MEDICATION ADHERENCE TRAINING INSTRUMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS;

ADULT; ANTI-RETROVIRAL AGENTS; BRAZIL; CLINICAL PROTOCOLS; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; KAPLAN-MEIER ESTIMATE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84864037382     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.011268     Document Type: Article

References (43)

1. Bongertz V, Bou-Habib DC, Castello-Branco LRR, Morgado MG. (2005) Report of the fifth Brazilian symposium on HIV/AIDS research. Mem Inst Oswaldo Cruz 2005;100:67-71
2. Levi GC, Vitoria MA. Fighting against AIDS: the Brazilian experience. AIDS 2002;16:2373-2383
3. Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003;17:1675-1682
4. Mocroft A, Vella S, Benfield T, et al. Changing patterns of mortality across Europe in patients infected with HIV. Lancet 1998;3521:1725-1730
5. Brazilian Ministry of Health. Adesão ao Tratamento Antiretroviral no Brasil: Coletaĉnea de Estudos do Projeto ATAR. [Adherence to Antiretroviral therapy in Brasil: Studies from the ATAR Project]. Brasilia, DF: Department of STD, Aids and Viral Hepatitis 2010
6. Blatt CR, Citadin CB, Souza FG, Mello RS, Galato D. Avaliação da adesão aos anti-retrovirais em um municipio no Sul do Brasil. [Assessment of adherence to antiretroviral drugs in a municipality in southern Brazil]. Rev Soc Bras Med Trop 2009;42:131-136
7. Bonolo Pde F, Cesar CC, Acurcio FA, et al. Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 2005;19(Suppl. 4):S5-S13
8. Hofer CB, Schechter M, Harrison LH. Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2004;36:967-971
9. Nemes MI, Carvalho HB, Souza MF. Antiretroviral therapy adherence in Brazil. AIDS 2004;18(Suppl. 3):S15-S20
10. Silva MC, Ximenes RA, Miranda Filho DB, et al. Risk-factors for non-adherence to antiretroviral therapy. Rev Inst Med Trop Sao Paulo 2009;51:135-139
11. Garcia R, Badaro R, Netto EM, et al. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses 2006;22:1248-1252
12. Rocha GM, Machado CJ, Acurcio Fde A, Guimaraes MD. Monitoring adherence to antiretroviral treatment in Brazil: an urgent challenge. Cad Saúde Pública 2011;27(Suppl. 1):S67-S78
13. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med 2000;50:1599-1605
14. Amico KR, Toro-Alfonso J, Fisher JD. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care 2005;17:661-673
15. Max B, Renslow S. Management of adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis 2000;30:96-106
16. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-1983
17. Moatti JP, Spire B, Kazatchkine M. Drug resistance and adherence to HIV/ AIDS antiretroviral treatment: against a double standard between the north and the south. AIDS 2004;18(Suppl. 3):S55-S61
18. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2002;133:21-30
19. Brigido L, Rodrigues R, Casseb J, et al. Impact of Adherence to Antiretroviral Therapy in HIV-1-Infected Patients at a University Public Service in Brazil. Aids Patient Care STDs 2001;15:587-93
20. Pinheiro C, Carvalho-Ieite J, Drachler M, Silveira V. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Boil Res 2002;35:1173-1181
21. Carmody ER, Diaz T, Starling P, dos Santos AP, Sacks HS. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic. Trop Med Int Health 2003;8:378-385
22. Cingolani A, Antinori A, Rizzo MG, et al. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA). AIDS 2002;16:369-379
23. Cook JA, Burke-Miller JK, Cohen MH, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 2008;22:1355-1363
24. Brazilian Health Ministry. Adesão ao tratamento. [Treatment adherence.]. In: Hallal R, ed. Recomendações para Terapia Anti-retroviral em Adultos Infectados pelo HIV [Antiretroviral Therapy for HIV Infection in Adults]. 7th edn. Brasilia, DF: National Program for STD and AIDS; 2008
25. Nemes M. Aderência ao tratamento por anti-retrovirais em serviços públicos no estado de São Paulo [Adherence to Antiretroviral Therapy in the Public Health Services of São Paulo State]. São Paulo: Ministry of Health 2000
26. Nemes M, Souza M, Kalichman A, et al. Antiretroviral (ARV) adherence prevalence in São Paulo, Brazil. International Conference on AIDS, Chennai, India, 2000
27. Brasilian Health Ministry. Diretrizes para o fortalecimento das ações de adesão ao tratamento para pessoas que vivem com HIV e AIDS. [Directives to Maximize the Adherence to HAART for People Living with HIV/AIDS]. Brasilia, DF: National Program on STD and AIDS, 2007
28. Weiss SM, Tobin JN, Antoni M, et al. Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J Womens Health 2011;3:63-77
29. Rueda S, Park-Wyllie LY, Bayoumi AM, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev 2006;3:CD 001442
30. Jones DL, McPherson-Baker S, Lydston D, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women's Project. AIDS Behav 2007;11:79-86
31. Garcia R, Schooley R, Badaro R. An adherence trilogy is essential for long-term HAART success. Braz J Infect Dis 2003;7:307-314
32. Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33
33. McPherson-Baker S, Jones D, Duran RE, Klimas N, Schneiderman N. Development and implementation of a medication adherence training instrument for persons living with HIV: the MATI. Behav Modif 2005;29:286-317
34. Associação Nacional de Empresas de Pesquisa (ANEP). Critério de Classificação Econômica Brasil. See www.datavale-sp.com.br/CCEB.pdf., 2000 (Last checked 15 June 2011)
35. Zubaran C, Foresti K, Schumacher M, et al. (2010) The Portuguese version of the breastfeeding self-efficacy scale-short form. J Hum Lact 2010;26:297-303
36. Zubaran C, Foresti K, Schumacher MV, et al. Validation of a screening instrument for postpartum depression in Southern Brazil. J Psychosom Obstet Gynaecol 2009;30:244-54
37. Zubaran C, Foresti K, Thorell MR, Franceschini PR, Homero W. Portuguese version of the quality of life enjoyment and satisfaction questionnaire: a validation study. Rev Panam Salud Publica 2009;25:443-448
38. Zubaran C, Persch K, Tarso D, Ioppi AE, Mezzich J. The Portuguese version of the personal health scale: a validation study in Southern Brazil. Clinics (São Paulo) 2007;62:419-26
39. Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol 2008;27:159-169
40. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 2003;17:283-290
41. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003;34:281-288
42. Bagshaw SM, Bellomo R. The need to reform our assessment of evidence from clinical trials: a commentary. Philos Ethics Humanit Med 2008;30:3-23
43. Whitley E, Ball J. Statistics review 4: sample size calculations. Crit Care 2002;6:335-341